Darius Kharabi

Insider Reports History

Location
Watertown, MA
Signature
/s/ Mary Reumuth, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Darius Kharabi:

Company Role Class Num Shares Value Price $ Report Date Ownership
KALA BIO, Inc. CHIEF BUSINESS OFFICER Common Stock 41,760 $85,608 $2.05 22 Oct 2025 Direct
KALA BIO, Inc. CHIEF BUSINESS OFFICER Stock Option (right to buy) 45,200 06 Jan 2025 Direct

Insider Reports Filed by Darius Kharabi

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KALA KALA BIO, Inc. 22 Oct 2025 1 -$17,269 4 CHIEF BUSINESS OFFICER 24 Oct 2025, 20:00
KALA KALA BIO, Inc. 24 Jun 2025 1 -$18,089 4 CHIEF BUSINESS OFFICER 26 Jun 2025, 20:00
KALA KALA BIO, Inc. 03 Jun 2025 1 -$2,730 4 CHIEF BUSINESS OFFICER 04 Jun 2025, 20:00
KALA KALA BIO, Inc. 06 Jan 2025 3 -$15,420 4 CHIEF BUSINESS OFFICER 07 Jan 2025, 20:14
KALA KALA BIO, Inc. 26 Jun 2024 1 -$24,500 4 CHIEF BUSINESS OFFICER 27 Jun 2024, 20:00
KALA KALA BIO, Inc. 31 May 2024 1 -$1,407 4 CHIEF BUSINESS OFFICER 03 Jun 2024, 20:00
KALA KALA BIO, Inc. 04 Jan 2024 3 -$9,321 4 CHIEF BUSINESS OFFICER 05 Jan 2024, 16:06
KALA Kala Pharmaceuticals, Inc. 22 Jun 2023 2 $0 4 CHIEF BUSINESS OFFICER 23 Jun 2023, 20:00
KALA Kala Pharmaceuticals, Inc. 14 Mar 2023 1 $0 4 CHIEF BUSINESS OFFICER 15 Mar 2023, 20:00
KALA Kala Pharmaceuticals, Inc. 15 Feb 2023 5 $0 4 CHIEF BUSINESS OFFICER 02 Jun 2023, 20:00
KALA Kala Pharmaceuticals, Inc. 04 Jan 2023 1 $0 4 CHIEF BUSINESS OFFICER 06 Jan 2023, 19:00
KALA Kala Pharmaceuticals, Inc. 15 Nov 2021 2 $0 4 CHIEF BUSINESS OFFICER 17 Nov 2021, 19:02
KALA Kala Pharmaceuticals, Inc. 15 Nov 2021 0 $0 3 CHIEF BUSINESS OFFICER 17 Nov 2021, 19:02